Zomedica Corp. financial data

Symbol
ZOM on NYSE
Industry
Pharmaceutical Preparations
Location
100 Phoenix Drive, Suite 125, Ann Arbor, Michigan
State of incorporation
Alberta, Canada
Fiscal year end
December 31
Former names
Zomedica Pharmaceuticals Corp. (to 9/28/2020)
Latest financial report
10-Q - Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.44 K % -29.8%
Quick Ratio 56.7 % +24.9%
Debt-to-equity 5.49 % +13.4%
Return On Equity -3.69 % +49.4%
Return On Assets -3.5 % +49.8%
Operating Margin -166 % -36.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 980 M shares 0%
Common Stock, Shares, Outstanding 980 M shares 0%
Entity Public Float 193 M USD -9.27%
Common Stock, Value, Issued 381 M USD 0%
Weighted Average Number of Shares Outstanding, Basic 980 M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 980 M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.26 M USD -69.7%
Cost of Revenue 2.15 M USD -64.8%
Research and Development Expense 1.77 M USD -43.7%
Selling and Marketing Expense 4.11 M USD
General and Administrative Expense 8.63 M USD
Operating Income (Loss) -10.4 M USD +58.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.33 M USD +56.3%
Income Tax Expense (Benefit) -166 K USD +91.2%
Net Income (Loss) Attributable to Parent -9.16 M USD +52.9%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted -0.03 USD/shares -50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.9 M USD +31%
Accounts Receivable, after Allowance for Credit Loss, Current 1.65 M USD +285%
Inventory, Net 5.06 M USD +84.5%
Assets, Current 92.1 M USD -29.3%
Property, Plant and Equipment, Net 24 M USD +253%
Operating Lease, Right-of-Use Asset 2.25 M USD +49.1%
Intangible Assets, Net (Excluding Goodwill) 54.8 M USD +13.2%
Goodwill 61.6 M USD -3.75%
Other Assets, Noncurrent 819 K USD +209%
Assets 244 M USD -12.8%
Contract with Customer, Liability, Current 260 K USD +7.44%
Liabilities, Current 8.01 M USD -6.85%
Contract with Customer, Liability, Noncurrent 279 K USD +6.08%
Deferred Income Tax Liabilities, Net 955 K USD -23.3%
Operating Lease, Liability, Noncurrent 1.66 M USD +76.1%
Other Liabilities, Noncurrent 907 K USD -53.8%
Liabilities 11.8 M USD -28.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -15 K USD +97.3%
Retained Earnings (Accumulated Deficit) -180 M USD -26.1%
Stockholders' Equity Attributable to Parent 232 M USD -11.8%
Liabilities and Equity 244 M USD -12.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.59 M USD -78.3%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 5.63 M USD
Common Stock, Shares, Issued 980 M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.68 M USD -101%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.9 M USD +31%
Deferred Tax Assets, Valuation Allowance 23.4 M USD +23.4%
Deferred Tax Assets, Gross 30.4 M USD +23.8%
Operating Lease, Liability 2.73 M USD +57.1%
Depreciation 334 K USD +104%
Payments to Acquire Property, Plant, and Equipment 2.34 M USD +141%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.22 M USD +54.1%
Lessee, Operating Lease, Liability, to be Paid 3.11 M USD +66.8%
Property, Plant and Equipment, Gross 26.2 M USD +219%
Operating Lease, Liability, Current 847 K USD +32.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 632 K USD -6.92%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.07 M USD +51.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +44.4%
Deferred Income Tax Expense (Benefit) -184 K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 377 K USD +202%
Lessee, Operating Lease, Liability, to be Paid, Year Three 603 K USD +154%
Unrecognized Tax Benefits 265 K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 569 K USD +189%
Operating Lease, Payments 1.07 M USD +152%
Amortization of Intangible Assets 1.6 M USD +33.2%
Share-based Payment Arrangement, Expense 5.6 M USD -26.5%
Interest Expense 50 K USD